Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001922964-23-000008
Filing Date
2023-10-10
Accepted
2023-10-10 16:15:44
Documents
1
Period of Report
2023-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1696968933.html 4  
1 FORM 4 wk-form4_1696968933.xml 4 3427
  Complete submission text file 0001922964-23-000008.txt   4755
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Muzzey Dale (Reporting) CIK: 0001922964 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 231318166